Healthcare of Ontario Pension Plan Trust Fund Sells 409,294 Shares of Lam Research Corporation $LRCX

Key Points

• Healthcare of Ontario Pension Plan Trust Fund cut its Lam Research position by 45.2% in the fourth quarter, selling 409,294 shares and leaving it with 496,300 shares valued at about $84.96 million.
• Lam Research reported strong quarterly results, beating EPS and revenue estimates, with revenue up 23.8% year over year and earnings guidance pointing to continued momentum.
• Wall Street remains broadly optimistic, with 28 Buy ratings and a consensus Moderate Buy rating, while analysts have lifted price targets as demand tied to AI and semiconductor equipment spending stays strong.

Healthcare of Ontario Pension Plan Trust Fund trimmed its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 45.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 496,300 shares of the semiconductor company's stock after selling 409,294 shares during the period. Healthcare of Ontario Pension Plan Trust Fund's holdings in Lam Research were worth $84,957,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of LRCX. PMV Capital Advisers LLC bought a new stake in shares of Lam Research in the fourth quarter valued at about $25,000. Stance Capital LLC bought a new stake in shares of Lam Research in the third quarter valued at about $26,000. Triumph Capital Management bought a new stake in shares of Lam Research in the third quarter valued at about $27,000. Core Wealth Advisors LLC bought a new stake in shares of Lam Research in the fourth quarter valued at about $29,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the second quarter valued at about $29,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Stock Performance

LRCX opened at $366.81 on Monday. Lam Research Corporation has a 52-week low of $87.75 and a 52-week high of $373.82. The firm has a market capitalization of $458.72 billion, a PE ratio of 69.21, a PEG ratio of 3.02 and a beta of 1.85. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54. The business's 50-day simple moving average is $286.10 and its 200 day simple moving average is $234.16.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.11. The firm had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The business's revenue for the quarter was up 23.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 5.7 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.3%. Lam Research's payout ratio is presently 19.62%.

Wall Street Analysts Forecast Growth

LRCX has been the topic of a number of research reports. UBS Group restated a "buy" rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Susquehanna boosted their price target on Lam Research from $350.00 to $385.00 and gave the company a "positive" rating in a report on Thursday, April 23rd. Bank of America boosted their price target on Lam Research from $285.00 to $330.00 and gave the company a "buy" rating in a report on Thursday, April 23rd. Sanford C. Bernstein boosted their price target on Lam Research from $325.00 to $340.00 and gave the company an "outperform" rating in a report on Thursday, May 21st. Finally, Erste Group Bank lowered Lam Research from a "buy" rating to a "hold" rating in a report on Thursday, April 2nd. Twenty-eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $322.01.

Insider Buying and Selling

In related news, insider Ava Harter sold 6,010 shares of the business's stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the transaction, the insider directly owned 53,205 shares of the company's stock, valued at approximately $13,762,005.30. The trade was a 10.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Neil J. Fernandes sold 18,170 shares of the business's stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $255.14, for a total value of $4,635,893.80. Following the transaction, the senior vice president directly owned 66,129 shares in the company, valued at $16,872,153.06. The trade was a 21.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 31,839 shares of company stock worth $8,561,667 over the last three months. 0.31% of the stock is owned by insiders.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research is benefiting from renewed optimism around wafer-fab equipment demand, with management recently raising its 2026 WFE market forecast to $140 billion and analysts lifting price targets on expectations that AI-driven chip investment will stay strong. Article Title
• Positive Sentiment: Recent coverage highlighted Lam Research as a core beneficiary of the AI infrastructure boom, with Barclays reiterating constructive views on chip-equipment names and investors focusing on ongoing spending for new semiconductor supply. Article Title
• Positive Sentiment: Lam Research’s recent earnings outperformance and upbeat guidance continue to support the bullish case, with the company beating estimates and projecting stronger revenue momentum into upcoming quarters. Article Title
• Neutral Sentiment: Some recent pieces focus on valuation after the AI-driven rally, suggesting investors are now weighing how much upside is already priced in after a sharp run-up. Article Title
• Negative Sentiment: Broader semiconductor stocks have remained volatile, and one recent session saw LRCX fall more steeply than the market, showing that the stock can still be pressured by sector-wide AI and macro swings. Article Title

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.